Will Canagliflozin Lend Credence to the Potential Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Renal Endpoints in Diabetic Nephropathy.
Will Canagliflozin Lend Credence to the Potential Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Renal Endpoints in Diabetic Nephropathy.
Am J Nephrol. 2017 Dec 11;46(6):459-461
Authors: Neumiller JJ, Rhee CM, Kalantar-Zadeh K
PMID: 29227973 [PubMed - as supplied by publisher]
Source: American Journal of Nephrology - Category: Urology & Nephrology Authors: Neumiller JJ, Rhee CM, Kalantar-Zadeh K Tags: Am J Nephrol Source Type: research